Clinical Trials Browser

Phase 2 × Unknown × gemcitabine-oxaliplatin regimen × Clear all

NCT05036798 2022-09-07

Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System.

Phase 2 Unknown

Gastrointestinal

Potentially Resectable Locally Advanced Malignant Tumors of Biliary System

NCT04948788 2021-09-28

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, B-Cell